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Anti-biofilmAbstract A simple, efficient and eco-friendly method for the synthesis of 1,2-dihydroquinazolines
has been developed using three-component reaction of readily available aromatic aldehydes,
2-aminobenzophenones, ammonium acetate with sulfamic acid as a green and recyclable catalyst.
The significant features of this method include short reaction time, operational simplicity, high
yields and high selectivity. Interestingly, the catalyst can be recovered and reused for up to four
cycles without any loss in catalytic activity. By employing this method, a series of 23 compounds
was synthesized and tested for antimicrobial activity against both Gram-positive and
Gram-negative bacterial strains as well as a fungal strain. Among these, compounds 4l, 4v and
4w showed appreciable antibacterial activity selectively against Gram-positive bacteria, wherein
compound 4w exhibited promising antibacterial activity with MIC value of 0.010 lMol L1 against
Staphylococcus aureusMTCC 96 andMicrococcus luteusMTCC 2470. In addition, 4w also showed
promising bactericidal and biofilm formation inhibitory effects.
 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Among azaheterocycles, the quinazoline scaffold is frequently
found in a wide range of natural products, pharmaceutical
drug compounds and functional materials. Various biological
activities exhibited by quinazoline derivatives include antibac-
terial (Grovera and Kini, 2006; Kung et al., 1999), antitumor
(Henderson et al., 2006; Noolvi et al., 2011), antiplasmodial
(Kabri et al., 2010; Verhaeghe et al., 2008), anti-
inflammatory (Balakumar et al., 2010), antiviral (Chien
et al., 2004) and anti-oxidant (Kumar et al., 2011) activities,bacterial
2 A. Kamal et al.apart from their usage as photo-chemotherapeutic agents
(Barraja et al., 2011). DNA-gyrase, JAK2, PDE5, EGFR tyr-
osine kinase (Boyapati et al., 2010; Yang et al., 2011; Kim
et al., 2008; Cruz-Lopez et al., 2011), T-type calcium channel
(Seo et al., 2007) and CB2 receptor (Saari et al., 2011) are
familiar targets of various quinazoline derivatives. This scaf-
fold is also the building block for many naturally occurring
alkaloids found across the plant and animal kingdoms
including microorganisms such as Bouchardatia neurococca,
Peganum nigellastrum, Bacillus cereus and Dichroa febrifuga
(Yoshida et al., 1991; Wattanapiromsakul et al., 2003; Deng
et al., 2000; Ma et al., 1997). The structures of some of the
pharmaceutically important quinazoline derivatives are given
in Fig. 1.
Owing to extensive applications of quinazoline derivatives in
various fields, several methods for their synthesis such as
copper-catalyzed cascade coupling of 2-bromobenzaldehyde
with acetamidine hydrochloride (Huang et al., 2008), cyclization
of substituted methanoneoximes by photochemical
methods (Alonso et al., 2010), tandem reaction from
2-aminobenzophenones and benzylic amines (Zhang et al.,
2010; Han et al., 2011), maltose–urea–NH4Cl mixture as a sol-
vent synthesis (Zhang et al., 2012), copper-catalyzed Ullmann
N-arylation coupling process (Truong and Morrow, 2010; Qiu
et al., 2010), copper-catalyzed alkynylation and cyclization of
N-phenylbenzamidines (Ohta et al., 2010), the use of microwave
irradiation (Kumar et al., 2005; Portela-Cubillo et al., 2009) and
the condensation of aldehydes with 2-aminobenzylamine using
either sodium hypochlorite (Maheswari et al., 2010) or MnO2
(Peng et al., 2010) as oxidant have been developed.
Furthermore, only few methods have been reported for the
synthesis of 1,2-dihydroquinazolines in the literature
(Finch and Gschwend, 1971; Carrington, 1955; Bergman
et al., 1986; Strekowski et al., 1988; Portela et al., 2008;
Rupam and Dipak, 2011; Chamseddine et al., 2014).
Nevertheless, they often suffer from one or more disadvantages
such as use of expensive catalyst, use of microwave, and forma-
tion of mixture of dihydroquinazoline and aromatized
quinazoline.
The use of solid acids as heterogeneous catalysts has signif-
icance in organic synthesis. Heterogeneous solid acids are use-
ful over conventional homogeneous acid catalysts as they canFigure 1 Structures of some of the pharmace
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tion and can be reused after activation or without activation,
making it economically more feasible. During the last few
years, sulfamic acid has been used as an efficient heterogeneous
acid catalyst for acid-catalyzed reactions. Sulfamic acid is a
stable, low-cost (`2.5/g), non-hygroscopic, non-corrosive,
non-volatile and highly efficient as well as a green catalyst
(Rostami and Tavakoli, 2011; Heravi et al., 2008) in the
organic synthesis. Moreover it is a recyclable and reusable cat-
alyst due to its high level of miscibility in water soluble
(0.2 g/1 g water @ 20 C). It has been used as an efficient
heterogeneous acid catalyst for acetalization (Jin et al.,
2002), esterification of cyclic olefins with aliphatic acids under
solvent-free conditions (Wang et al., 2004a,b), acetylation of
alcohols and phenols (Tong-shou, 1998), tetrahydropyranyla-
tion of hydroxyl compound (Wang et al., 2003), transesterifica-
tion of b-ketoesters (Bo et al., 2003), Biginelli condensation (Li
et al., 2003), Beckmann rearrangement (Wang et al., 2004a,b),
inter and intramolecular imino Diels–Alder reactions
(Nagarajan et al., 2004), Pechmann condensation (Sing et al.,
2004), Hantzsch reaction (Foroughifar et al., 2009), Mannich
reaction (Zeng et al., 2009), and Michael reaction (Li-Tao
et al., 2007).
In continuation to our efforts in developing environmen-
tally benign methods for the synthesis of bioactive compounds
(Kamal et al., 2014, 2015a,b,c,d) and to overcome the
disadvantages of the previous methods we have developed an
efficient method for the synthesis of 1,2-dihydroquinazolines
using sulfamic acid as a catalyst. We herein report a
green, simple and practical method for the synthesis of
1,2-dihydroquinazolines via A three-component reaction using
aromatic aldehydes, 2-aminobenzophenones and ammonium
acetate catalyzed by sulfamic acid.2. Experimental section
All chemicals and reagents were obtained from Aldrich
(Sigma–Aldrich), St. Louis, MO, USA), Lancaster (Alfa
Aeser, Johnson Matthey Company, Ward Hill, MA, USA),
or Spectrochem Pvt. Ltd. (Mumbai, India) and were used
without further purification. Reactions were performed byutically important quinazoline derivatives.
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Efficient and green sulfamic acid catalyzed synthesis 3TLC on silica gel glass plate containing 60 GF-254, and visu-
alization was achieved by UV light or iodine indicator. 1H and
13C NMR spectra were determined in CDCl3 by using Varian
and Avance instruments. Chemical shifts are expressed in parts
per million (d in ppm) downfield from internal TMS and cou-
pling constants are expressed in Hz. 1H NMR spectroscopic
data are reported in the following order: multiplicity (s, singlet;
brs, broad singlet; d, doublet; dd, doublet of doublets; t, tri-
plet; m, multiplet), coupling constants in Hz, number of pro-
tons. ESI mass spectra were recorded on a Micro mass
Quattro LC using ESI + software with capillary voltage
3.98 kV and an ESI mode positive ion trap detector. Melting
points were determined with an Electro thermal melting point
apparatus, and are uncorrected.
2.1. General procedure for the synthesis of 1,2-
dihydroquinazolines
A mixture of 2-aminobenzophenone (1 mmol), benzaldehyde
(1 mmol), dry ammonium acetate (2 mmol) and SA (20 mol
%) in EtOH (5 mL) were heated at 60 C. After completion
of the reaction monitored by TLC, the reaction mixture was
cooled and ice-cold water was added and stirred for 5 min.
The solid product obtained was filtered and washed with
water. All the compounds were further purified by crystalliza-
tion from ethanol or by preparative TLC (n-hexane/ethyl
acetate: 5/1). The catalyst was quantitatively recovered by
the evaporation of the filtrate under reduced pressure. The
recovered catalyst could be reused for up to four cycles after
washing with diethyl ether and drying.
2.2. Antimicrobial activity assay
The antimicrobial activity of the synthesized 1,2-
dihydroquinazoline derivatives was determined using well dif-
fusion method (Amsterdam, 1996) against different pathogenic
Gram-positive bacterial strains such as Bacillus subtilisMTCC
121, Staphylococcus aureus MTCC 96, S. aureus MLS16
MTCC 2940 and Micrococcus luteus MTCC 2470 as well as
Gram-negative bacterial strains such as Klebsiella planticola
MTCC 530, Escherichia coli MTCC 739 and Pseudomonas
aeruginosa MTCC 2453 along with Candida albicans MTCC
3017 procured from the Microbial Type Culture Collection
and Gene Bank (MTCC), CSIR-Institute of Microbial Tech-
nology, Chandigarh, India. The pathogenic reference strains
were seeded on the surface of the Muller–Hinton agar Petri
plates with 0.1 ml of previously prepared microbial suspen-
sions individually containing 1.5  108 cfu ml1 (equal to 0.5
McFarland standard). Wells of 6.0 mm diameter were pre-
pared in the media plates using a cork borer and the synthe-
sized compounds dissolved in 10% DMSO at a dose range
of 125–0.97 lg were added in each well under sterile conditions
in a laminar air flow chamber. Standard antibiotic solutions of
Ciprofloxacin (for bacterial strains) and Miconazole (for C.
albicans) at a dose range of 125–0.97 lg well1, served as pos-
itive controls, while the well containing DMSO served as neg-
ative control. In the present study Ciprofloxacin has been used
since it is a broad spectrum antimicrobial standard drug. The
plates were incubated for 24 h at 37 C for bacteria and 30 C
for C. albicans. The well containing the least concentration
showing the inhibition zone is considered as the minimumPlease cite this article in press as: Kamal, A. et al., Eﬃcient and green sulfamic acid
potential. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2inhibitory concentration. All experiments were carried out in
duplicates and mean values are represented.
2.3. Minimum bactericidal concentration (MBC) assay
The MBC assay (National Committee for Clinical Laboratory
Standards, 2000) was performed in sterile 2.0 mL microfuge
tubes against a panel of pathogenic bacterial strains, including
B. subtilis MTCC 121, S. aureus MTCC 96, S. aureus MLS-16
MTCC 2940 and M. luteus MTCC 2470 were cultured
overnight in Mueller Hinton broth. Serial dilutions of test
compounds were prepared in Mueller Hinton broth with
different concentrations ranging from 0 to 125 lg mL1. To
the test compounds, 100 lL of overnight cultured bacterial
suspensions was added to reach a final concentration of
1.5  108 cfu mL1 (equal to 0.5 McFarland standard) and
incubated at 37 C for 24 h. After 24 h of incubation, the min-
imum bactericidal concentration (MBC) was determined by
sampling 10 lL of suspension from the tubes onto
Mueller Hinton agar plates and was incubated for 24 h at
37 C to observe the growth of test organisms. MBC is the
lowest concentration of test compound required to kill a
particular bacterium strain. All the experiments were carried
in duplicates.
2.4. Biofilm inhibition assay
The test compounds were screened in sterile 96 well polystyr-
ene microtiter plates using the modified biofilm inhibition
assay (Kamal et al., 2015a,b,c,d), against a panel of
pathogenic bacterial strains including B. subtilis MTCC
121, S. aureus MTCC 96, S. aureus MLS-16 MTCC 2940
and M. luteus MTCC 2470 which were cultured overnight
in tryptone soy broth (supplemented with 0.5% glucose).
The test compounds of predetermined concentrations rang-
ing from 0 to 250 lg mL1 were mixed with the bacterial
suspensions having an initial inoculum concentration of
5  105 CFU mL1. Aliquots of 100 lL were distributed in
each well and then incubated at 37 C for 24 h under static
conditions. The medium was then discarded and washed
with phosphate buffered saline to remove the non-adherent
bacteria. Each well of the microtiter plate was stained with
100 lL of 0.1% crystal violet solution followed by 30 min.,
incubation at room temperature. Later, the crystal violet
solution from the plates was discarded, thoroughly washed
with distilled water for 3–4 times and air dried at room tem-
perature. The crystal violet stained biofilm was solubilized in
95% ethanol (100 lL) and the absorbance was recorded at
540 nm using TRIAD multimode reader (Dynex Technolo-
gies, Inc, Chantilly, VA, USA). Blank wells were employed
as background check. The inhibition data were interpreted
from the dose–response curves, where IC50 value is defined
as the concentration of inhibitor required to inhibit 50%
of bio-film formation under the above assay conditions.
All the experiments were carried out in triplicates and the
values are indicated as mean ± S.D.
2.5. Cytotoxicity assay
Cytotoxicity of the compound 4w was determined on the basis
of measurement of in vitro growth inhibition of the normalcatalyzed synthesis of new 1,2-dihydroquinazoline derivatives with antibacterial
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Table 2 Screening of the amount of catalyst required for the
transformation.
Entry SA (mole%) Yielda (%)
4 A. Kamal et al.lung cell line, IMR-90 (ATCC No. CCL-186), in 96 well plate
by cell-mediated reduction of tetrazolium salt to water insol-
uble formazan crystals using MTT assay (Mosmann, 1983).
The IC50 values (50% inhibitory concentration) were calcu-
lated from the plotted absorbance data for the dose–response
curves. IC50 values (in lM) are expressed as the mean ± S.D
of three independent experiments.
3. Results and discussion
3.1. Chemistry
Initially a reaction was performed using 2-
aminobenzophenone (1), 4-nitrobenzaldehyde (2) and
ammonium acetate (3) in water without any catalyst at room
temperature and under refluxing conditions for 180 min, and
the reaction was monitored by TLC (Scheme 1). It was
observed that the reaction did not proceed. When the same
reaction was carried out using various solvents such as
CH3CN, MeOH and EtOH at room temperature, the desired
transformation was accomplished in the yields <5%, 34%
and 42%, respectively (Table 1, entry 3–5). As MeOH and
EtOH provided significant yields of the product, the condensa-
tion was then conducted in the same solvents at different
temperatures such as 40, 60 and 80 C. The yields improved
considerably especially at 60 C (Table 1, entries 6–10). Later,Scheme 1 Model reaction.
Table 1 Screening of different solvents at various
temperatures.
Entry Solvent Temperature
(C)
Catalyst
(20 mol%)
Time
(min)
Yielda
(%)
1 Water RT – 180 –
2 Water Reflux – 180 –
3 CH3CN RT – 60 <5
4 Methanol RT – 60 34
5 Ethanol RT – 60 42
6 Methanol 40 – 60 54
7 Ethanol 40 – 60 62
8 Methanol 60 – 60 66
9 Ethanol 60 – 60 72
10 Ethanol 80 – 80 74
11 Methanol RT SA 60 62
12 Ethanol RT SA 60 70
13 Methanol 40 SA 40 72
14 Ethanol 40 SA 40 78
15 Methanol 60 SA 20 85
16 Ethanol 60 SA 20 96
17 Ethanol 60 SA 60 96
18 Ethanol 80 SA 20 96
a Isolated yields.
Please cite this article in press as: Kamal, A. et al., Eﬃcient and green sulfamic acid
potential. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2this reaction was carried out in the presence of catalytic
amount (20 mol%) of SA in MeOH and EtOH at different
temperatures (Table 1, entries 12–18). The reaction proceeded
well furnishing improved yields of the product as compared to
the uncatalyzed reaction at room temperature. With the
increase in temperature up to 60 C, yields of the product were
improved; however, further increase in temperature to 80 C
did not improve the yields. Interestingly, in the presence of
the SA as catalyst at 60 C, excellent yield (96%) of the pro-
duct was observed in 20 min in EtOH as a solvent. Therefore,
EtOH was found to be the suitable solvent at 60 C that
provides higher yields (Table 1, entry 16). It is important
to note that under the conditions mentioned above 1,2-
dihydroquinazoline is formed as an exclusive product. In order
to validate this, the reaction was continued for additional
40 min (Table 1, entry 17), and interestingly no aromatic
quinazoline was obtained. This indicates the selectivity of the
reaction conditions furnishing only 1,2-dihydroquinazoline
without any traces of quinazoline as aromatized product.1 5 52
2 10 65
3 15 87
4 20 96
5 30 96
a Isolated yields.
Table 3 Reaction conditions for the synthesis of different 1,2-
dihydroquinazolines.
Entry Compound X R Time
(min)
Yielda
(%)
1 4a H 4-NO2 20 96
2 4b H 3-NO2 30 89
3 4c H 2-Cl,5-NO2 30 90
4 4d H 4-Cl,3-NO2 35 88
5 4e H 4-CN 20 94
6 4f H 4-Cl 30 85
7 4g H 4-Br 30 83
8 4h H 4-OMe 20 93
9 4i H 3-OMe 30 87
10 4j H 3,4-DiOMe 25 92
11 4k H 3,4,5-TriOMe 25 90
12 4l H 3-OH,4-OMe 30 83
13 4m NO2 4-NO2 30 87
14 4n NO2 3-NO2 35 83
15 4o NO2 2-Cl,5-NO2 40 84
16 4p NO2 4-Cl,3-NO2 40 81
17 4q NO2 4-CN 30 90
18 4r NO2 4-Cl 35 82
19 4s NO2 4-Br 35 81
20 4t NO2 4-OMe 35 87
21 4u NO2 3,4-DiOMe 40 85
22 4v NO2 3,4,5-TriOMe 40 83
23 4w NO2 3-OH,4-OMe 45 81
a Isolated yields.
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Efficient and green sulfamic acid catalyzed synthesis 5Overall, excellent to very good yields of the desired 1,2-
dihydroquinazolines were obtained with this protocol employ-
ing SA as the catalyst.
After optimizing the reaction with respect to time and tem-
perature, the amount of catalyst required for the desired trans-
formation was examined. The reaction was performed using 5,
10, 15, 20 and 30 mol% of sulfamic acid. It was found that
while increasing the amount of SA from 5 mol% to 10, 15,
and 20 mol%, the yields increased from 52% to 65%, 87%
and 96%, respectively (Table 2, entries 1–4). Further increasing
the amount of SA from 20 mol% to 30 mol% did not improve
the yield (96%) of the product (Table 2, entry 5). Therefore, it
could be concluded that 20 mol% of SA, in ethanol at 60 C for
20 min were the required conditions for this transformation.
After optimizing the reaction conditions, the scope
of the reaction was investigated by employing two
2-aminobenzophenones (unsubstituted and 5-nitro) with
several aromatic aldehydes and the results to this regard are
summarized in Table 3 (Scheme 2). It was observed that, the
aromatic aldehydes with both electron donating and electron
withdrawing substituents react well providing very good yields
(81–96%) of the corresponding products. However, in case of
halogen substituted benzaldehydes, the reaction is slower and
the yields are comparatively low (Table 3, entries 6, 7, 18
and 19). It was also observed that, the position of the sub-
stituent played a significant effect on the reaction. Benzaldehy-
des with m-substitution gave lower yields (Table 3, entries 2, 9
and 14) as compared to their p-substituted counterpartsScheme 2 SA catalyzed synthesis of
Figure 2 Plausible mechanism for the f
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in the case of benzaldehydes having di- and tri- substitution.
Logically, the presence of an electron withdrawing group at
position 5 of the 2-aminobenzophenone, slowed down the
reaction resulting in comparably longer reaction time and
lower yields (Table 3, entry 13–23). Therefore, by applying this
method twenty three compounds have been prepared out of
which nineteen compounds were new.
3.2. Plausible mechanism
The plausible mechanism for the formation of 1,2-
dihydroquinazolines from a three component reaction of alde-
hyde, 2-aminobenzophenone and ammoniumacetate is outlined
in Fig. 2. The reaction is presumed to proceed with the forma-
tion of aldimine (A) from 2-aminobenzophenone and aldehyde.
This step is promoted by the catalyst sulfamic acid and later
ammonium acetate reacts with the keto group to form diimine
(B)with the expulsion ofwater and acetic acid. The aldimine car-
bon that is susceptible for a nucleophilic attack is attacked by
ketimino nitrogen atom to cyclize into a conformationally
favorable six membered ring thereby forming the product (C).3.3. Reusability of the catalyst
The reusability of sulfamic acid is one of the most important
advantages of this protocol that makes it useful for practicaldifferent 1,2-dihydroquinazolines.
ormation of 1,2-dihydroquinazoline.
catalyzed synthesis of new 1,2-dihydroquinazoline derivatives with antibacterial
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Table 4 Yields of the product with various cycles of the
catalyst.
Entry Reaction cycle Yielda (%)
1 1st cycle (Fresh run) 96
2 2nd cycle 95
3 3rd cycle 94
4 4th cycle 93
5 5th cycle 92
a Isolated yields.
Table 6 Minimum bactericidal concentration (MBC) of the
promising compounds.
Compound Minimum bactericidal concentration (MBC,
lMol L1)
B.sa S.ab S.ac M.ld
4l 0.094 0.047 0.094 0.189
4v 0.074 0.149 0.074 0.037
4w 0.041 0.010 0.020 0.010
Ciprofloxacin 0.004 0.002 0.002 0.004
a Bacillus subtilis MTCC 121.
b Staphylococcus aureus MTCC 96.
c Staphylococcus aureus MLS16 MTCC 2940.
d Micrococcus luteus MTCC 2470.
6 A. Kamal et al.industrial applications. Thus in this process the catalyst used
was recovered as mentioned in the experimental procedure.
Interestingly, the recovered catalyst could be reused for up
to four cycles. When the catalyst was used in the fresh run
(for model reaction), yield of the product was 96% and when
the same catalyst was reused up to four times under similar
conditions the yields obtained were 95%, 94%, 93% and
92%, respectively (Table 4, entries 1–5). Thus, the catalyst
showed excellent recyclability in all these reactions which is
evident from the reaction times and yields being almost same
without any loss of catalytic activity.Table 5 Antimicrobial activity of the compounds against different
Compound Minimum inhibitory concentration (MIC, lMol L
B.sa S.ab S.ac M.
4a >0.379 >0.379 >0.379 >0
4b >0.379 >0.379 >0.379 >0
4c >0.344 >0.344 >0.344 >0
4d >0.344 >0.344 >0.344 >0
4e >0.404 >0.404 >0.404 >0
4f >0.393 >0.393 >0.393 >0
4g >0.344 >0.344 >0.344 >0
4h >0.398 >0.398 >0.398 >0
4i >0.396 >0.396 >0.396 >0
4j >0.364 >0.364 >0.364 >0
4k >0.334 >0.334 >0.334 >0
4l 0.094 0.047 0.094 0.1
4m >0.334 >0.334 >0.334 >0
4n >0.334 >0.334 >0.334 >0
4o >0.306 >0.306 >0.306 >0
4p >0.306 >0.306 >0.306 >0
4q >0.353 >0.353 >0.353 >0
4r >0.344 >0.344 >0.344 >0
4s >0.306 >0.306 >0.306 >0
4t >0.348 >0.348 >0.348 >0
4u >0.321 >0.321 >0.321 >0
4v 0.074 0.149 0.074 0.0
4w 0.041 0.010 0.020 0.0
Ciprofloxacin 0.002 0.002 0.002 0.0
Miconazole – – – –
a Bacillus subtilis MTCC 121.
b Staphylococcus aureus MTCC 96.
c Staphylococcus aureus MLS16 MTCC 2940.
d Micrococcus luteus MTCC 2470.
e Klebsiella planticola MTCC 530.
f Escherichia coli MTCC 739.
g Pseudomonas aeruginosa MTCC 2453.
h Candida albicans MTCC 3017.
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4.1. Antimicrobial activity
All the synthesized 1,2-dihydroquinazoline derivatives were
evaluated for their antimicrobial activity using well diffusionmicrobial strains.
1)
ld K.pe E.cf P.ag C.ah
.379 >0.379 >0.379 >0.379 >0.379
.379 >0.379 >0.379 >0.379 >0.379
.344 >0.344 >0.344 >0.344 >0.344
.344 >0.344 >0.344 >0.344 >0.344
.404 >0.404 >0.404 >0.404 >0.404
.393 >0.393 >0.393 >0.393 >0.393
.344 >0.344 >0.344 >0.344 >0.344
.398 >0.398 >0.398 >0.398 >0.398
.396 >0.396 >0.396 >0.396 >0.396
.364 >0.364 >0.364 >0.364 >0.364
.334 >0.334 >0.334 >0.334 >0.334
89 >0.378 >0.378 >0.378 >0.378
.334 >0.334 >0.334 >0.334 >0.334
.334 >0.334 >0.334 >0.334 >0.334
.306 >0.306 >0.306 >0.306 >0.306
.306 >0.306 >0.306 >0.306 >0.306
.353 >0.353 >0.353 >0.353 >0.353
.344 >0.344 >0.344 >0.344 >0.344
.306 >0.306 >0.306 >0.306 >0.306
.348 >0.348 >0.348 >0.348 >0.348
.321 >0.321 >0.321 >0.321 >0.321
37 >0.300 >0.300 >0.300 >0.300
10 >0.333 >0.333 >0.333 >0.333
02 0.002 0.002 0.002 -
– – – 0.018
catalyzed synthesis of new 1,2-dihydroquinazoline derivatives with antibacterial
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Table 7 Anti-biofilm activity of the promising compound.
Compound IC50 values (lMol L
1)
B.sa S.ab S.ac M.ld
4l 0.038 ± 0.36 0.024 ± 0.23 0.054 ± 0.34 0.090 ± 0.32
4v 0.032 ± 0.48 0.070 ± 0.52 0.033 ± 0.36 0.018 ± 0.24
4w 0.019 ± 0.45 0.005 ± 0.22 0.011 ± 0.22 0.006 ± 0.16
Ciprofloxacin 0.002 ± 0.08 0.001 ± 0.07 0.001 ± 0.11 0.001 ± 0.09
a Bacillus subtilis MTCC 121.
b Staphylococcus aureus MTCC 96.
c Staphylococcus aureus MLS16 MTCC 2940.
d Micrococcus luteus MTCC 2470.
Efficient and green sulfamic acid catalyzed synthesis 7method (Amsterdam, 1996) against both Gram-positive bacte-
rial strains such as B. subtilisMTCC 121, S. aureusMTCC 96,
S. aureusMLS16 MTCC 2940 andM. luteus MTCC 2470 and
Gram-negative bacterial strains such as K. planticola MTCC
530, E. coli MTCC 739 and P. aeruginosa MTCC 2453. The
minimum inhibitory concentration (MIC) values for some of
the active compounds are represented in Table 5 and were
compared with the widely used antibiotic Ciprofloxacin. From
the results, it is evident that some of these compounds have
demonstrated very good inhibition of bacterial growth. Com-
pounds such as 4l, 4v and 4w showed potent appreciable
antimicrobial activity specifically against the Gram-positive
bacteria. Among these compounds, 4w exhibited very good
antimicrobial activities with MIC values of 0.010, 0.041,
0.020 and 0.010 lMol L1 against B. subtilis MTCC 121, S.
aureusMTCC 96, S. aureusMLS16 MTCC 2940 andM. luteus
MTCC 2470, respectively. However, some of the synthesized
compounds were found to be inactive even at the maximum
concentration used for testing. From a structure–activity rela-
tionship perspective, the compound 4w bears a NO2 sub-
stituent on the quinazoline ring which has a strong electron
withdrawing property which may be contributing to the
promising antimicrobial activity specifically to the Gram pos-
itive bacterial strains. However, it did not exhibit promising
activity against the Gram negative bacterial strains and
C. albicans. In case of compound 4l, the OH group is on ben-
zene ring (2nd position) without NO2 group on the quinazoline
ring, while compound 4v bears a NO2 group on the quinazo-
line ring and a trimethoxy group on the benzene ring (2nd
position) which exhibited good to moderate antimicrobial
activity with MIC values ranging between 0.037 and
0.189 lMol L1 against the above mentioned four Gram-
positive bacterial strains. In addition, all the compounds were
evaluated for their antifungal potential against the fungal
strain C. albicansMTCC 3017 in comparison with Miconazole
as standard drug. However, these compounds were found to be
inactive against this fungal strain. Further, the compound 4w,
when checked for its cytotoxic role against IMR-90, normal
lung cell line, it was found that the IC50 value was
217.17 lM which suggests that the compound 4w was found
to be non-cytotoxic.
4.2. Minimum bactericidal concentration (MBC)
Based on the antibacterial activity results, the compounds 4l,
4v and 4w were further screened for the minimum bactericidal
concentration (MBC) against four bacterial strains namely B.Please cite this article in press as: Kamal, A. et al., Eﬃcient and green sulfamic acid
potential. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2subtilis MTCC 121, S. aureus MTCC 96, S. aureus MLS16
MTCC 2940 and M. luteus MTCC 2470 by MBC assay
(National Committee for Clinical Laboratory Standards,
2000). The results of MBC assay are shown in Table 6. Com-
pound 4w once again proved to be a very good antibacterial
agent with MBC values of 0.010, 0.020 and 0.010 lMol L1
against S. aureus MTCC 96, S. aureus MLS16 MTCC 2940
and M. luteus MTCC 2470, respectively. However, the com-
pounds 4l and 4v exhibited good to moderate bactericidal
activities with MBC values ranging between 0.037 and
0.189 lMol L1.
4.3. Biofilm inhibition activity
The compounds exhibited antibacterial and bactericidal prop-
erties were also checked using the modified biofilm inhibition
assay (Kamal et al., 2015a,b,c,d). In this regard, derivatives
4l, 4v and 4w were screened for anti-biofilm activity against
B. subtilis MTCC 121, S. aureus MTCC 96, S. aureus
MLS16 MTCC 2940 and M. luteus MTCC 2470 which are
common and important nosocomial pathogens having an abil-
ity to form biofilms. The results summarized in Table 7,
showed that these three compounds exhibited excellent to good
anti-biofilm activities. In this case too, compound 4w effec-
tively inhibited the biofilm formation with IC50 values ranging
between 0.005 and 0.019 lMol L1 against the four Gram pos-
itive bacterial strains. Compounds 4l and 4v with good
antibacterial activities also exhibited good to moderate anti-
biofilm activity. Based on the above studies, the compound
4w was identified as a lead candidate exhibiting promising
antibacterial and anti-biofilm activities.5. Conclusion
In conclusion, a simple, general, mild, efficient and environ-
mentally benign method for the synthesis of 1,2-
dihydroquinazolines was developed using sulfamic acid as a
green catalyst. The advantages of this method include its selec-
tivity, and no aromatized product was obtained. More impor-
tantly, the catalyst could be recovered and reused for the next
cycle thereby reducing the waste. Furthermore, using this
method a series of twenty three 1,2-dihydroquinazoline deriva-
tives have been synthesized and screened for their antimicro-
bial and anti-biofilm activities. Among the tested
compounds, 4w was considered as a potent candidate exhibit-
ing promising antibacterial and anti-biofilm activities. Thiscatalyzed synthesis of new 1,2-dihydroquinazoline derivatives with antibacterial
015.10.013
8 A. Kamal et al.compound has a basic dihydroquinazoline scaffold bearing a
NO2 substituent on the quinazoline ring which shows strong
electron withdrawing property and thus exhibits both antibac-
terial activity and antagonism toward the biofilm formation.Acknowledgments
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